Skip to content
CancerIndex

Comparison engine

Compare cancers

Two to four cancers side by side. Only facts present in the database are shown; every figure carries its source, period and unit. Entities at different hierarchy depths are labelled so counts are not read as equivalent.

Malignant Pancreatic NeoplasmMalignant Lung NeoplasmGlioblastoma

Compare 2 to 4 cancers. The selection is in the URL — copy it to share this comparison.

Facts

Taxonomy

FactMalignant Pancreatic NeoplasmMalignant Lung NeoplasmGlioblastoma
CancerIndex IDCI-CAN-00001159CI-CAN-00001140CI-CAN-00000934
Entity typeCancerCancerSubtype
Hierarchy depth444
Top-level registry siteYesYesNo — nearest: Malignant Central Nervous System Neoplasm (3 levels up)
Parents
NCIt / OncoTreeC9005C7377C3058 · GB
BadgesSolid tumorTop-levelrarity unknownSolid tumorTop-levelrarity unknownSolid tumorrarity unknown

Taxonomy from NCIt / OncoTree (Curated). Badges are rule-derived from stored attributes.

Facts

US registry figures (latest year available per metric)

FactMalignant Pancreatic NeoplasmMalignant Lung NeoplasmGlioblastomaregistry level: Malignant Central Nervous System Neoplasm
US annual deaths51,327count2024 · both sexes · all agescdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observed		128,762count2024 · both sexes · all agescdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observed		18,523count2024 · both sexes · all agescdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observedfigures for Malignant Central Nervous System Neoplasm
US annual new cases61,467count2023 · both sexes · all agescdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observed		228,058count2023 · both sexes · all agescdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observed		22,882count2023 · both sexes · all agescdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observedfigures for Malignant Central Nervous System Neoplasm
US age-standardized mortality11.3per 100,0002024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observed		28per 100,0002024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observed		4.4per 100,0002024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderProvenance
Source
CDC WONDER — Underlying Cause of Death (US mortality by ICD-10 site)
Dataset
CDC WONDER Underlying Cause of Death, 2018-2024, Single Race
Version
D158 vintage 2024
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain) subject to CDC WONDER data use restrictions (statistical reporting only; counts ≤ 9 must not be published; no re-identification)
Run
ING-CDCWONDER-20260908-000001
Open at source Observedfigures for Malignant Central Nervous System Neoplasm
US age-standardized incidence13.9per 100,0002023 · both sexes · all ages · 2000 U.S. standard populationcdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observed		50.1per 100,0002023 · both sexes · all ages · 2000 U.S. standard populationcdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observed		5.8per 100,0002023 · both sexes · all ages · 2000 U.S. standard populationcdc-uscsProvenance
Source
U.S. Cancer Statistics (USCS) — NPCR/SEER incidence and NVSS mortality
Dataset
U.S. Cancer Statistics — Data Visualizations tool data tables (BYSITE.TXT)
Version
USCS 1999-2023 ASCII package, Nov 2025 submission (last-modified Thu, 04 Jun 2026 20:40:00 GMT; sha256 291765c997e5)
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
registry
License
US Government work (public domain); citation requested; statistical reporting and analysis only; no linkage for re-identification
Run
ING-CDCUSCS-20260908-000001
Open at source Observedfigures for Malignant Central Nervous System Neoplasm

Observations as published (site definitions on each entity's Statistics tab). No global figures: IARC / GLOBOCAN is under license review and SEER awaits credentials. For entities below the top level the nearest top-level ancestor's registry figures are shown and labelled; they describe the whole site group, not the subtype.

Facts

Counters (entity + descendants)

FactMalignant Pancreatic NeoplasmMalignant Lung NeoplasmGlioblastoma
Active trials904clinicaltrialsComputed2,644clinicaltrialsComputed486clinicaltrialsComputed
Recruiting trials506clinicaltrialsComputed1,428clinicaltrialsComputed260clinicaltrialsComputed
Active Phase III trials69clinicaltrialsComputed382clinicaltrialsComputed29clinicaltrialsComputed
Publications, last 5 years25,767pubmedComputed93,034pubmedComputed24,612pubmedComputed
Publications, last 12 months5,402pubmedComputed19,659pubmedComputed5,286pubmedComputed
Curated evidence items63civicComputed619civicComputed43civicComputed
Genes with evidence112civicComputed803civicComputed100civicComputed
Genomic cohorts14gdcComputed41gdcComputed1gdcComputed
Drugs (any / approved)32 / 8civicComputed128 / 51civicComputed20 / 2civicComputed

Counts aggregate over descendants across hierarchy types, so a broad family counts more than one of its subtypes; publication counts are query-based per entity. Counters refreshed 2026-09-29.

Facts

Current ranks

FactMalignant Pancreatic NeoplasmMalignant Lung NeoplasmGlioblastoma
Annual deaths#2 of 3151,326 count · USA · both sexes · all ages · 2024 · top-level cancersHigh confidence#1 of 31128,663 count · USA · both sexes · all ages · 2024 · top-level cancersHigh confidence#9 of 3118,523 count · USA · both sexes · all ages · 2024 · top-level cancersHigh confidencerank of Malignant Central Nervous System Neoplasm
Annual new cases#10 of 3261,467 count · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#3 of 32228,058 count · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#17 of 3222,882 count · USA · both sexes · all ages · 2023 · top-level cancersHigh confidencerank of Malignant Central Nervous System Neoplasm
Age-standardized mortality rate#2 of 2311.3 per 100,000 · USA · both sexes · all ages · 2024 · top-level cancersHigh confidence#1 of 2327.9 per 100,000 · USA · both sexes · all ages · 2024 · top-level cancersHigh confidence#8 of 234.3 per 100,000 · USA · both sexes · all ages · 2024 · top-level cancersHigh confidencerank of Malignant Central Nervous System Neoplasm
Age-standardized incidence rate#9 of 2413.9 per 100,000 · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#2 of 2450.1 per 100,000 · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#15 of 245.8 per 100,000 · USA · both sexes · all ages · 2023 · top-level cancersHigh confidencerank of Malignant Central Nervous System Neoplasm
Mortality-to-incidence ratio#1 of 310.8 ratio · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#7 of 310.58 ratio · USA · both sexes · all ages · 2023 · top-level cancersHigh confidence#3 of 310.8 ratio · USA · both sexes · all ages · 2023 · top-level cancersHigh confidencerank of Malignant Central Nervous System Neoplasm
Trial Gap Index#4 of 31+16.7 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidence#13 of 310 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidence#20 of 31-3.4 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidencerank of Malignant Central Nervous System Neoplasm
Research Gap Index#3 of 31+20 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidence#12 of 31+3.3 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidence#1 of 31+70 percentile points · USA · both sexes · all ages · 2024 · top-level cancersMedium confidencerank of Malignant Central Nervous System Neoplasm
Active clinical trials#7 of 36904 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#1 of 362,644 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#81 of 1,654486 count · World · both sexes · all ages · latest · all malignant entitiesMedium confidence
Recruiting clinical trials#7 of 36506 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#1 of 361,428 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#81 of 1,277260 count · World · both sexes · all ages · latest · all malignant entitiesMedium confidence
Active Phase III trials#11 of 3669 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#1 of 36382 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#122 of 81029 count · World · both sexes · all ages · latest · all malignant entitiesMedium confidence
Publications, last 5 years#8 of 3625,767 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#2 of 3693,034 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#33 of 2,87324,612 count · World · both sexes · all ages · latest · all malignant entitiesMedium confidence
Publications, last 12 months#6 of 365,402 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#2 of 3619,659 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#27 of 2,2945,286 count · World · both sexes · all ages · latest · all malignant entitiesMedium confidence
Publication growth#7 of 361.23 ratio · World · both sexes · all ages · latest · top-level cancersMedium confidence#5 of 361.24 ratio · World · both sexes · all ages · latest · top-level cancersMedium confidencenot ranked
Curated clinical evidence items#8 of 2863 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#2 of 28619 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#90 of 49243 count · World · both sexes · all ages · latest · all malignant entitiesMedium confidence
Genes with curated or cohort evidence#19 of 30112 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#1 of 30803 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#172 of 521100 count · World · both sexes · all ages · latest · all malignant entitiesMedium confidence
Public genomic cohorts#10 of 2714 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#1 of 2741 count · World · both sexes · all ages · latest · top-level cancersMedium confidence#228 of 2961 count · World · both sexes · all ages · latest · all malignant entitiesMedium confidence

Ranks come from current snapshots (metric × scope × formula version); "of n" is the number of eligible entities in that scope. Top-level entities are ranked among the 36 mutually exclusive site groups, others among all malignant entities — the two are not comparable. Versioning.

Charts

Side by side

Bars are proportional within each chart; missing values are shown as a dash, never as zero.

US annual deathscount
  1. Malignant Pancreatic Neoplasm51,327
    2024 · observed
  2. Malignant Lung Neoplasm128,762
    2024 · observed
  3. Glioblastoma18,523
    2024 · observed · registry level: Malignant Central Nervous System Neoplasm

Registry observation · latest year · Observed

US age-standardized mortalityper 100,000
  1. Malignant Pancreatic Neoplasm11.3
    2024 · observed
  2. Malignant Lung Neoplasm28
    2024 · observed
  3. Glioblastoma4.4
    2024 · observed · registry level: Malignant Central Nervous System Neoplasm

Per 100,000 · standard population declared by the source

Active trialscount
  1. Malignant Pancreatic Neoplasm904
    ClinicalTrials.gov · entity + descendants
  2. Malignant Lung Neoplasm2,644
    ClinicalTrials.gov · entity + descendants
  3. Glioblastoma486
    ClinicalTrials.gov · entity + descendants

Counter · Computed

Publications, last 5 yearscount
  1. Malignant Pancreatic Neoplasm25,767
    PubMed · stored query per entity
  2. Malignant Lung Neoplasm93,034
    PubMed · stored query per entity
  3. Glioblastoma24,612
    PubMed · stored query per entity

Counter · Computed

Comparisons juxtapose facts of different natures (registry counts, registrations, literature volume). They are not a judgment of severity or priority, and population figures never describe an individual.

Data updated 16 hours agoSource updated unknowneach cell states its own period and source